Page last updated: 2024-10-23

bumetanide and Hypertension, Malignant

bumetanide has been researched along with Hypertension, Malignant in 1 studies

Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.

Research Excerpts

ExcerptRelevanceReference
"A case is presented in which a 34-year-old man with renal insufficiency and malignant hypertension develops acute pancreatitis with abdominal symptoms and hyperamylasemia after being treated with loop diuretics (furosemide and bumetanide)."3.67Loop diuretic-induced pancreatitis with rechallenge in a patient with malignant hypertension and renal insufficiency. ( Alvestrand, A; Stenvinkel, P, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stenvinkel, P1
Alvestrand, A1

Other Studies

1 other study available for bumetanide and Hypertension, Malignant

ArticleYear
Loop diuretic-induced pancreatitis with rechallenge in a patient with malignant hypertension and renal insufficiency.
    Acta medica Scandinavica, 1988, Volume: 224, Issue:1

    Topics: Adult; Amylases; Bumetanide; Diuretics; Furosemide; Humans; Hypertension, Malignant; Kidney Failure,

1988